Table 3. Proportions of various immune cell populations within the PPs following vehicle and oxaliplatin treatment.
Immune cell population | Vehicle | Oxaliplatin |
---|---|---|
Macrophages | 1.3 ± 0.1 | 1.1 ± 0.3 |
Dendritic cells | 2.9 ± 0.3 | 2.5 ± 0.7 |
Eosinophils: MHC-II+ MHC-II- |
0.8 ± 0.2 0.6 ± 0.1 |
0.7 ± 0.01 0.7 ± 0.1 |
NK cells | 1.7 ± 0.5 | 3.3 ± 1.1 |
γδ T cells | 0.7 ± 0.01 | 0.8 ± 0.04 |
B cells | 53.1 ± 1.4 |
45.5 ± 3.4 |
CD4+ T cells | 56.0 ± 17.0 | 52.3 ± 14.8 |
CD8+ T cells | 6.9 ± 1.8 |
10.1 ± 2.7 |
NKT cells | 0.4 ± 0.1 |
0.6 ± 0.17 |